MYGN insider trading
Open-market stock trades by Myriad Genetics (MYGN) executives and directors: who bought or sold, how many shares, at what price and when.
MYGN insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Kumar Rashmi | director | Sell | 15,000 | $4.46 | $66.84K |
| May 14, 2026 | Bisaro Paul | director | Buy | 7,500 | $3.69 | $27.64K |
| Mar 9, 2026 | Raha Samraat S. | President and CEO | Buy | 40,000 | $5.00 | $199.84K |
| Feb 27, 2026 | Phanstiel S. Louise | director | Buy | 48,000 | $4.66 | $223.73K |
| Feb 26, 2026 | Phanstiel S. Louise | director | Buy | 50,407 | $4.80 | $242.10K |
| Feb 25, 2026 | Phanstiel S. Louise | director | Buy | 6,100 | $4.74 | $28.89K |
- MYGN insiders bought $722.20K and sold $66.84K in open-market trades over their last 6 filings.
Updated 2026-11-05 12:51 UTC